Kyiv: Scientists of the biotechnological company Moderna announced the successful result of testing a new type of Coronavirus infection vaccine, says the company on its official website.
"After using the vaccine, the number of antibodies in the volunteers either exceeded a similar indicator in the blood of those who had been ill with the coronavirus, or were at the same level," says the report.
First phase of clinical trials was conducted in early April.
We add that the second phase of testing is scheduled for July 2020.
“At the first stage, the drug proved to be safe, it is tolerated without complications,” the scientists emphasized.
Recall, US President Donald Trump said that American scientists have selected the 14 best vaccines from Coronavirus, which will be conducted clinical trials in the near future.